Annals of Neurology · 2012 · 103 citations · 16 references
MedicineNeurosciencePharmacologyElectrophysiologyIon Channel BiophysicsNeuropharmacologyIon Channel DisordersIon Channel PharmacologyIon Channel PhysiologyIon Channel SignalingIon ChannelsMigraine PharmacotherapyAcid-sensing Ion ChannelsEpithelial Sodium ChannelsHeadache PathophysiologyIon Channel TargetsMigraine AuraMigraine PharmacologyMigraine With AuraTherapeutic Target Identification
OBJECTIVE: Migraine with aura is a severe debilitating neurological disorder with few relatively specific therapeutic options. METHODS: We used amiloride, a blocker of epithelial sodium channels, to evaluate its pharmacological potential and explored the biology of a potential mechanism of action in well-established experimental models. RESULTS: Amiloride was shown to block cortical spreading depression, the experimental correlate of aura, and inhibited trigeminal activation in in vivo migraine models, via an acid-sensing ion channel 1 mechanism. Remarkably, amiloride then demonstrated good clinical efficacy in a small open-labeled pilot study of patients, reducing aura and headache symptoms in 4 of 7 patients with otherwise intractable aura. INTERPRETATION: The observations here identify an entirely novel treatment strategy for migraine.
16
The International Classification of Headache Disorders: 2nd edition
Jes Olesen, Peter J. Goadsby, Tim Steiner · The Lancet Neurology · 2003 · 5.1K citations
Medicine, Neurology, Psychiatry +13
Peter J. Goadsby · Cephalalgia · 2004 · 2.4K citations · Full text
Migraine prevalence, disease burden, and the need for preventive therapy
Richard B. Lipton, Marcelo E. Bigal, Merle L. Diamond et al. · Neurology · 2007 · 2.3K citations · Full text
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
Hayrünnisa Bolay, Uwe Reuter, Andrew K. Dunn et al. · Nature Medicine · 2002 · 1.2K citations